Access Medical Ventures

Access Medical Ventures is a North Haven, Connecticut-based venture capital firm founded in 2010, specializing in early-stage medical device and life sciences investments. The firm focuses primarily on interventional and therapeutic medical device companies, backed by a two-partner team that provides both capital and operational expertise to founders navigating the complex medical device regulatory and commercialization landscape. Checks range from $500,000 to $3 million at seed and Series A stages across the United States. The portfolio of 22 investments includes CartiHeal, a cartilage repair device company that was acquired on August 30, 2021; MinInvasive, a minimally invasive surgical device startup; and Revamp Medical, a therapeutic device company. Access Medical Ventures frequently co-invests alongside other healthcare-focused funds including Elron Ventures, a structure that allows portfolio companies to access deeper networks and follow-on capital from multiple institutional partners. Access Medical Ventures operates with a clear thesis: medical device innovation requires investors with the domain expertise to evaluate clinical evidence, regulatory pathways, and reimbursement dynamics alongside commercial potential. The firm's concentrated focus on interventional and therapeutic devices — rather than digital health or diagnostics — reflects a deliberate specialization in the hardware and materials science layer of medical technology. Founders benefit from direct engagement with partners who understand the specific challenges of FDA clearance, clinical trials, and hospital procurement that define the medical device commercialization path.